This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
earnings-estimates: Archive
MaxCyte, Inc. (MXCT) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
MaxCyte (MXCT) delivered earnings and revenue surprises of -20.00% and -14.93%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
MXCTPositive Net Change IOVANegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Amtech Systems (ASYS) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Amtech (ASYS) delivered earnings and revenue surprises of +175.00% and +22.23%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ASYSPositive Net Change NVDAPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
biote Corp. (BTMD) Tops Q2 Earnings Estimates
by Zacks Equity Research
biote Corp. (BTMD) delivered earnings and revenue surprises of +66.67% and -1.37%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
BTMDPositive Net Change VREXPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Global Net Lease (GNL) Beats Q2 FFO Estimates
by Zacks Equity Research
Global Net Lease (GNL) delivered FFO and revenue surprises of +20.00% and -18.37%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
GNLNo Net Change RLJPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Lyft (LYFT) Lags Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Lyft (LYFT) delivered earnings and revenue surprises of -7.41% and -1.49%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
LYFTPositive Net Change LPSNPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Adma Biologics (ADMA) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Adma Biologics (ADMA) delivered earnings and revenue surprises of +7.14% and +0.73%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ADMAPositive Net Change PBYINegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Brookdale Senior Living (BKD) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Brookdale (BKD) delivered earnings and revenue surprises of -28.57% and -0.64%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
BKDPositive Net Change LCTXPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
F&G Annuities & Life, Inc. (FG) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
F&G Annuities & Life, Inc. (FG) delivered earnings and revenue surprises of +20.31% and +15.40%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
FGNegative Net Change BHFNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Chord Energy Corporation (CHRD) Lags Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Chord Energy Corporation (CHRD) delivered earnings and revenue surprises of -4.79% and -8.87%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CHRDNegative Net Change GRNTPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
EnerSys (ENS) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
EnerSys (ENS) delivered earnings and revenue surprises of +1.46% and +5.18%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ENSPositive Net Change LIQTPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
NextNav Inc. (NN) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Spartacus Acquisition (NN) delivered earnings and revenue surprises of -114.29% and -24.40%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
NNPositive Net Change GENNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
SkyWater Technology, Inc. (SKYT) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
SkyWater Technology (SKYT) delivered earnings and revenue surprises of +35.29% and +3.08%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
SKYTNegative Net Change GCTSNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Tarsus Pharmaceuticals, Inc. (TARS) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Tarsus Pharmaceuticals (TARS) delivered earnings and revenue surprises of -45.45% and +9.94%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
TARSPositive Net Change BFRINo Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Aligos Therapeutics, Inc. (ALGS) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Aligos Therapeutics (ALGS) delivered earnings and revenue surprises of +34.89% and -3.50%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ALGSPositive Net Change RGNXNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Amplify Energy (AMPY) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Amplify Energy (AMPY) delivered earnings and revenue surprises of -600.00% and +5.69%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
AMPYNegative Net Change HPKPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Certara, Inc. (CERT) Q2 Earnings Miss Estimates
by Zacks Equity Research
Certara (CERT) delivered earnings and revenue surprises of -30.00% and +0.98%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CERTPositive Net Change GLUENegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Mirum Pharmaceuticals, Inc. (MIRM) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Mirum Pharmaceuticals (MIRM) delivered earnings and revenue surprises of +61.29% and +17.88%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
MIRMNegative Net Change TCRXNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Niagen Bioscience (NAGE) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Niagen Bioscience (NAGE) delivered earnings and revenue surprises of +100.00% and +8.99%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
NAGEPositive Net Change CRVONegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Outset Medical, Inc. (OM) Reports Q2 Loss, Beats Revenue Estimates
by Zacks Equity Research
Outset Medical (OM) delivered earnings and revenue surprises of +52.27% and +5.54%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
OMPositive Net Change NYXHPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Plymouth Industrial (PLYM) Surpasses Q2 FFO and Revenue Estimates
by Zacks Equity Research
Plymouth Industrial (PLYM) delivered FFO and revenue surprises of +6.98% and +1.07%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
PLYMNegative Net Change COLDNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Zillow (Z) Q2 Earnings Lag Estimates
by Zacks Equity Research
Zillow (Z) delivered earnings and revenue surprises of -9.09% and +1.31%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ZNegative Net Change AKAMPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
DraftKings (DKNG) Q2 Earnings Miss Estimates
by Zacks Equity Research
DraftKings (DKNG) delivered earnings and revenue surprises of -7.32% and +5.99%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
DKNGPositive Net Change SLEPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Encore Capital Group (ECPG) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Encore Capital Group (ECPG) delivered earnings and revenue surprises of +72.92% and +15.50%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ECPGPositive Net Change GHIPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Jack In The Box (JACK) Q3 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Jack In The Box (JACK) delivered earnings and revenue surprises of -12.07% and -2.17%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
JACKNegative Net Change QSRPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Grand Canyon Education (LOPE) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Grand Canyon Education (LOPE) delivered earnings and revenue surprises of +11.68% and +3.02%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
LOPEPositive Net Change NRDYNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank